Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than
females and is attributed to historical differences in exposures with world-standardised …

The treatment paradigm for malignant pleural mesothelioma (MPM) has changed little in the
last 18 years. Radical intent treatment, consisting of surgical resection, radiotherapy and …

The management of pleural mesothelioma has changed with the demonstration that first-line
checkpoint blockade therapy improves survival. This review covers issues of relevance to …

Background Malignant pleural mesothelioma (MPM) has a poor overall survival with few
treatment options. Whole genome sequencing (WGS) combined with the immune features of …

Background The exact role and type of surgery for malignant pleural mesothelioma (MPM)
remains controversial. This study aimed at analyzing a 20-year single center perioperative …

Background Whether extrapleural pneumonectomy (EPP) or extended pleurectomy/
decortication (P/D) is the optimal resection for malignant pleural mesothelioma remains …

Simple Summary Platin-based chemotherapy with pemetrexed has been the backbone of
meaningful treatment in pleural mesothelioma for the last 16 years, alongside vinorelbine …

Malignant mesothelioma is a rare and aggressive cancer that develops in the thin layer
surrounding the mesothelium and is mainly caused by asbestos exposure. Despite …

Abstract Purpose of Review For patients with malignant pleural mesothelioma, prognosis is
poor with extremely low 5-year survival rates and limited therapeutic options. Here, we …

ABSTRACT Introduction Malignant mesothelioma (MMe) is an aggressive rare cancer of the
mesothelium, associated with asbestos exposure. MMe is currently an incurable disease at …